Stockreport

UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics

UTime Limited - Ordinary Shares  (WTO) 
PDF SHENZHEN, China, Aug. 29, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company"), which continues to build on its strengths in the global healthcare [Read more]